{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-187995","form_type":"8-K","ticker":"CERS","cik":"0001020214","company_name":"CERUS CORP","filed_at":"2022-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.611340+00:00","generated_at":"2026-06-24T21:10:07.516726+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Cerus appoints Dr. Hua Shan to Board of Directors effective July 1, 2022","bullets":["Dr. Hua Shan, Medical Director of Transfusion Medicine at Stanford, joins Cerus Board effective July 1, 2022.","She brings over 25 years of transfusion medicine experience, including expertise in Chinese blood bank practices.","Receives $45k annual cash retainer and initial equity grants valued at $150k in options and $150k in RSUs, vesting over 3 years.","Appointment supports Cerus's JV to bring INTERCEPT Blood System to China and global expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-187995","json":"https://secwatch.observer/filing/0001193125-22-187995.json","markdown":"https://secwatch.observer/filing/0001193125-22-187995.md","text":"https://secwatch.observer/filing/0001193125-22-187995.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1020214/000119312522187995/0001193125-22-187995-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1020214/000119312522187995/d357061d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T21:10:07.516726+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7ebec1bb5b","claim":"Hua Shan was appointed as Director at CERUS CORP.","evidence_excerpt":"the Board extended an offer to join the Board to Hua Shan, MD, PhD, and on June 30, 2022, Dr. Shan accepted such offer to join the Board, effective July 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312522187995/0001193125-22-187995-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}